NEOG
Neogen Corporation · Healthcare · Medical - Devices
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q2 2024
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q2 2026 | 100 | -3 | 145.70M | $1.31B | +8 | −10 |
| Q1 2026 | 105 | +4 | 149.62M | $1.39B | +10 | −7 |
| Q4 2025 | 101 | +1 | 145.41M | $1.02B | +3 | −1 |
| Q3 2025 | 15 | 0 | 86.70M | $495.04M | +1 | −2 |
| Q2 2025 | 13 | +1 | 84.31M | $402.96M | +2 | −1 |
| Q1 2025 | 9 | 0 | 40.38M | $350.08M | +1 | −1 |
| Q4 2024 | 9 | -2 | 40.94M | $497.00M | — | −2 |
| Q3 2024 | 10 | 0 | 36.89M | $620.15M | — | — |
| Q2 2024 | 10 | — | 39.27M | $613.84M | — | — |
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Norges Bank ✦ (passive) | 18.21M | — | $284.55M | 0.0% | n/c | 1 | SEC ↗ |
| 2 | Baillie Gifford ✦ | 11.58M | — | $181.01M | 0.1% | n/c | 1 | SEC ↗ |
| 3 | Baillie Gifford ✦ | 11.58M | — | $181.01M | 0.1% | n/c | 1 | SEC ↗ |
| 4 | Baillie Gifford ✦ | 11.58M | — | $181.01M | 0.1% | n/c | 1 | SEC ↗ |
| 5 | Baillie Gifford ✦ | 11.58M | — | $181.01M | 0.1% | n/c | 1 | SEC ↗ |
| 6 | Geode Capital Management ✦ (passive) | 5.13M | — | $80.16M | 0.0% | n/c | 1 | SEC ↗ |
| 7 | Geode Capital Management ✦ (passive) | 5.13M | — | $80.16M | 0.0% | n/c | 1 | SEC ↗ |
| 8 | Citadel Advisors ✦ | 2.80M | — | $43.80M | 0.0% | n/c | 1 | SEC ↗ |
| 9 | Millennium Management ✦ | 1.24M | — | $19.34M | 0.0% | n/c | 1 | SEC ↗ |
| 10 | T. Rowe Price ✦ | 133.20K | — | $2.08M | 0.0% | n/c | 1 | SEC ↗ |
| 11 | GAMCO Investors ✦ | 70.53K | — | $1.10M | 0.0% | n/c | 1 | SEC ↗ |
| 12 | AQR Capital Management ✦ | 58.20K | — | $906,818 | 0.0% | n/c | 1 | SEC ↗ |
| 13 | AQR Capital Management ✦ | 58.20K | — | $906,818 | 0.0% | n/c | 1 | SEC ↗ |
| 14 | Bridgewater Associates ✦ | 38.28K | — | $598,363 | 0.0% | n/c | 1 | SEC ↗ |
| 15 | Marshall Wace ✦ | 18.76K | — | $293,188 | 0.0% | n/c | 1 | SEC ↗ |
“Their weight” = the position's share of that manager's reported 13F equity value — the conviction measure. ✦ = curated manager.
New buyers
| No new tracked buyers this quarter. |
Exited
| No tracked exits this quarter. |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 307 holders, 232.63M shares, $1.97B reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
What else this security's tracked holders most often hold — shared-ownership counts, not fundamental relationships.